Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 153 participants.

Also called NCT07122167

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 153 participants (planned count) (from the registry)
Sponsor
MDCECRO LLC (from the registry)
Registry
  • NCT NCT07122167
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07122167. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-02 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
Condition
Peripheral Arterial Disease
Intervention (Device)
Peripheral Drug-eluting Stent System
Lead sponsor
MDCECRO LLC (class: research network)
Collaborator
Zylox-Tonbridge Medical Technology Co., Ltd. (class: not stated)

Record details

Record id
cardio:ct-nct07122167
Content hash
a1581360d5604c6d127bb6ecb5ad85f28e2810863f38f296440643a84c4dfcde